ARTICLE AD BOX
The U.S. Supreme Court has agreed to weigh in on the future of mifepristone, a drug used in more than half of all abortions in the United States, setting up another major dispute over abortion rights less than two years after the court’s conservative majority voted to overturn Roe v. Wade. The case, concerning the Food and Drug Administration’s approval of mifepristone, will be argued early next...